Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $174.75 USD
Change Today -5.33 / -2.96%
Volume 1.5M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sven Ante Lundberg M.D.

Former Head of Translational Medicine and Vice President, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

----

Background*

Dr. Sven Ante Lundberg, also known as Bill, MD has been Chief Scientific Officer of CRISPR Therapeutics AG since April 07, 2015. Dr. Lundberg served as Head of Translational Medicine and Vice President at Alexion Pharmaceuticals, Inc. Dr. Lundberg has a wealth of knowledge and experience in the fields of immunology and oncology. Dr. Lundberg served as Chief Medical Officer of Taligen Therapeutics, Inc. since April 2010. Dr. Lundberg has held senior clinical and medical ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Massachusetts Institute of Technology
MD
Stanford University School of Medicine
MBA
University of Massachusetts, Amherst

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $174.75 USD -5.33

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.